
2027 COMy Congress – May 13-16 2027 Paris, France
Join leading global experts at the World Congress on Controversies in Multiple Myeloma (COMy)—the premier international forum dedicated to advancing care for myeloma and plasma cell disorders. Designed to foster open debate and critical evaluation of clinical challenges, COMy brings together cutting-edge science, expert insights, and the latest therapeutic advances—from CAR T-cell therapy to measurable residual disease. With a unique format focused on real-time discussion and consensus-building, COMy is where science meets clinical practice. Don’t miss the opportunity to engage with world-renowned specialists and shape the future of myeloma treatment.
The aim of the congress
- Advancing education and research in the field of Multiple Myeloma by discussing, in a debate forum, evidence-based medicine and expert opinions on current controversial issues.
- Building a bridge between science and clinical practice, by presenting basic science and discussing its consolidation into clinical practice.
- Providing a stage where the newest studies are being presented in an interactive platform.
- To promulgate ethics and standards of practice and treatment.
- To reach consensus on certain controversial issues, through debates, round table discussions, and plenary lectures.
- To create a forum for the industry to meet with experts in the field, and to update international participants on pressing clinical and technological questions of the day
